Application 018655

Type
NDA
Sponsor
GD SEARLE LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NORPACE CRDISOPYRAMIDE PHOSPHATECAPSULE, EXTENDED RELEASE;ORALEQ 100MG BASEYesNo
002NORPACE CRDISOPYRAMIDE PHOSPHATECAPSULE, EXTENDED RELEASE;ORALEQ 150MG BASEYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0025-2732Norpace CRdisopyramide phosphateG.D. Searle LLC Division of Pfizer IncNDACurrent
0025-2732Norpace CRdisopyramide phosphateG.D. Searle LLC Division of Pfizer IncNDACurrent
0025-2732Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2732Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2732Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2732Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2732Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2732Norpace CRdisopyramide phosphateG.D. Searle LLC Division of Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphateG.D. Searle LLC Division of Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphatePfizer Laboratories Div Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphateG.D. Searle LLC Division of Pfizer IncNDACurrent
0025-2742Norpace CRdisopyramide phosphateG.D. Searle LLC Division of Pfizer IncNDACurrent
68151-0526Norpacedisopyramide phosphateCarilion Materials ManagementNDACurrent
68151-0527Norpacedisopyramide phosphateCarilion Materials ManagementNDACurrent